TenderDekho Logo
GEM

National Aluminium Company Limited insulin prefilled pen tender Angul Odisha 2026 Novo Nordisk authorization

Bid Publish Date

13-Feb-2026, 3:45 pm

Bid End Date

02-Mar-2026, 9:00 am

Location

Progress

Issue13-Feb-2026, 3:45 pm
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

650

Category

INSULIN DEGLUDEC 2.56 MG+ INSULIN ASPART 1.05MG PREFILLED PEN

Bid Type

Single Packet Bid

Categories 1

Tender Overview

Organization: National Aluminium Company Limited (NALCO), Bhubaneswar; Location: Angul, Odisha 759037; Product: insulin degludec + insulin aspart prefilled pen and insulin degludec injection 100IU/ml prefixed pen; Scope: Only supply of Goods with OEM authorization from Novo Nordisk India Pvt Ltd. Deliveries in two lots within six months; first lot: 50% of ordered quantity within 30 days of GeM contract; final inspection at NALCO Hospital; packing labeled “NALCO STOCK, NOT FOR SALE.”

  • Emphasis on authorized distributors/channel partners with principal vendor authorization
  • Clear requirement for genuine, quality product with batch traceability and shelf life controls
  • No BOQ quantity listed; emphasis on compliance with buyer-specified format and documentation

Technical Specifications & Requirements

  • Products must be the medicines as described: insulin degludec + insulin aspart in prefixed pens and insulin degludec inj 100IU/ml prefixed pen
  • Shelf life criteria: latest batch within 3 to 6 months from manufacturing; minimum expiry date 18 months from date of supply; minimum shelf life remaining 70% at delivery
  • Packaging/Labelling: specify packaging to prevent damage; imprint “NALCO STOCK, NOT FOR SALE” on all blister/packs
  • Authorization: submit OEM authorization specific to this GeM bid; resellers must provide manufacturer certification confirming genuineness of batches
  • Delivery & inspection: two lots within six months; initial 50% within 30 days; final acceptance at NALCO Hospital
  • Quality controls: certification that supplied medicines are genuine and meet the stated product description

Terms, Conditions & Eligibility

  • Delivery schedule: two lots within six months; 50% of quantity to be delivered within 30 days of GeM Contract
  • OEM authorization: tender-specific authorization certificate from Novo Nordisk India; signed by principal vendor with name, designation, contact
  • Shelf life requirements: batch within 3-6 months; expiry at least 18 months from supply; 70% shelf life at delivery
  • Packaging/labeling: proper protective packing; explicit labeling as specified
  • Inspection & acceptance: final inspection at NALCO Hospital; results final and binding
  • Near-expiry replacement: free replacement with fresh stock with two months notice prior to expiry
  • Documentation: submit all listed certificates, guarantee letters, and OEM authorization as per terms

Key Specifications

  • Product: insulin degludec + insulin aspart prefixed pen; insulin degludec injection 100IU/ml prefixed pen

  • Batch life: 3-6 months from manufacturing; expiry minimum 18 months from delivery; shelf life at least 70% on delivery

  • Labeling: include ‘NALCO STOCK, NOT FOR SALE’ on all packs

  • Delivery: two lots within six months; first lot 50% within 30 days

  • Authorization: tender-specific OEM authorization from Novo Nordisk India

  • Inspection: final acceptance at NALCO Hospital

Terms & Conditions

  • Two-lot delivery within six months with 50% within 30 days

  • OEM authorization from Novo Nordisk India required for tender participation

  • Shelf-life and expiry requirements with explicit batch dating and labeling

Important Clauses

Payment Terms

Not specified in the tender data; suppliers should anticipate standard procurement payment terms post-delivery subject to GeM contract and hospital acceptance.

Delivery Schedule

Two lots to be supplied within six months; first lot 50% of quantity within 30 days from GeM contract date.

Penalties/Liquidated Damages

Not specified; bidders should assume standard L.D. clauses in GeM contracts and hospital acceptance criteria.

Bidder Eligibility

  • Must hold valid GST registration and PAN

  • Must provide OEM authorization from Novo Nordisk India for this tender

  • Experience in supplying pharmaceutical medicines to government or large institutional buyers

Documents 11

GeM-Bidding-8952628.pdf

Main Document

Other Documents

OTHER

Technical Specification/Buyer Specification Document

TECHNICAL

Technical Specification/Buyer Specification Document

TECHNICAL

Other Documents

OTHER

Other Documents

OTHER

Other Documents

OTHER

Other Documents

OTHER

Other Documents

OTHER

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

INSULIN ASPART 30% + INSULIN ASPART PROTAMINE 70% INJECTION IN FLEXPEN

National Aluminium Company Limited, Bhubaneswar

ANGUL, ODISHA

Posted: 25 April 2025
Closed: 16 May 2025
GEM

INSULIN LISPRO (25% ) + INSULIN LISPRO PROTAMINE (75% ) 100IU/ML, 3ML CARTRIDGE

Bharat Coking Coal Limited

DHANBAD, JHARKHAND

Posted: 5 February 2025
Closed: 5 March 2025
GEM

HUMAN INSULIN 30% + ISOPHANE INSULIN 70% INJECTION 100IU/ML, DISPOSABLE PEN WITH 3ML CATRIDGE

National Aluminium Company Limited, Bhubaneswar

KORAPUT, ODISHA

Posted: 31 July 2025
Closed: 12 August 2025
GEM

Insulin 50% Lispro and 50% Insulin Lispro protamine suspension 100IU / Ml, 3 ml

Indian Army

CENTRAL DELHI, DELHI

Posted: 29 August 2025
Closed: 19 September 2025
GEM

CARTRIDGE INSULIN ASPART 30% + INSULIN ASPART PROTAMINE 70% 100 IU/ml

Nuclear Power Corporation Of India Limited

CHITTORGARH, RAJASTHAN

Posted: 20 February 2025
Closed: 1 May 2025
GEM

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Required Documents

1

GST registration certificate

2

PAN card

3

OEM authorization certificate from Novo Nordisk India Pvt Ltd specific to this GeM bid

4

Authority/authorization letter for distributor/dealer/channel partner

5

Quality guarantee certificate confirming genuineness of supplied medicines

6

Shelf life certificates (batch lot details, manufacturing date, expiry date)

7

Packing and labeling compliance statement

8

Delivery schedule plan for two lots within six months

9

Inspection report or acceptance criteria from NALCO Hospital

10

Any other certificates requested in the Terms and Conditions

Frequently Asked Questions

Key insights about ODISHA tender market

How to bid for insulin prefixed pen tender in Angul Odisha 2026?

Bidders must submit OEM authorization from Novo Nordisk India specific to this GeM bid, along with GST, PAN, and experience certificates. Include a compliant Format-T1 technical offer, and ensure packaging labels read ‘NALCO STOCK, NOT FOR SALE’. Delivery plan must cover two lots in six months with 50% within 30 days.

What documents are required for the Nalco insulin tender in Odisha?

Required documents include GST, PAN, OEM authorization from Novo Nordisk India, distributor authorization if applicable, quality guarantee letter, batch-specific shelf life certificates, packing/labeling compliance, and the delivery schedule for two lots within six months. Ensure hospital inspection readiness.

What shelf life criteria apply to medicines in this Nalco tender?

Medicines must be the latest batch within 3-6 months from manufacturing, with a minimum expiry date of 18 months from the date of supply, and at least 70% shelf life at delivery. Packing must clearly identify Nalco stock.

What are the delivery requirements for Nalco insulin supplies?

Delivery is in two lots within six months. The first lot must be delivered within 30 days from the GeM contract, representing 50% of the ordered quantity; final acceptance occurs at Nalco Hospital.

What are the labeling and packaging requirements for Nalco stock?

Packaging must protect contents during transit; all packs must carry the label 'NALCO STOCK, NOT FOR SALE' and comply with the stated product description to facilitate hospital inspection and acceptance.

How are OEM authorizations demonstrated for this tender in Odisha?

Submit an OEM authorization certificate from Novo Nordisk India tender-specific, signed by the principal vendor with official name, designation, and contact details; authorized distributors must also provide substantive authorization letters.

Who conducts final acceptance for insulin supplies under this Nalco tender?

Final acceptance is conducted by NALCO Hospital; inspection results are binding. Suppliers must ensure batch authenticity, shelf life compliance, and proper labeling before acceptance is granted.

What is the delivery timeline and quantity split for the two lots?

Total order is to be delivered in two lots over six months; 50% of the quantity should be delivered within 30 days of the GeM contract date for the first lot.